A Phase 2b, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study of HTX-019 as Treatment for Postoperative Nausea and Vomiting Following Failed Antiemetic Prophylaxis
Administered By
Awarded By
Contributors
- Habib, Ashraf Samir Principal Investigator
Start/End
- July 8, 2021 - June 30, 2024